BridgeBio Pharma Inc. (BBIO)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 481 |
| % of all portfolios: | 0.031% |
| Hold Price * : | $74.26 |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
| Q1 2026 | |||||
| ≡ | Viking Global Investors | Reduce 17.73% | 2,551,500 | 0.53 | |
| ≡ | Polen Capital Management | Add 20.12% | 7,693 | 0.00 | |
| Q4 2025 | |||||
| ≡ | Viking Global Investors | Reduce 9.91% | 1,583,915 | 0.32 | |
| ≡ | Polen Capital Management | Add 5.74% | 2,077 | 0.00 | |
| Q3 2025 | |||||
| ≡ | Viking Global Investors | Reduce 13.89% | 2,577,526 | 0.35 | |
| ≡ | Polen Capital Management | Add 1.44% | 515 | 0.00 | |
| Q2 2025 | |||||
| ≡ | Viking Global Investors | Reduce 15.87% | 3,500,000 | 0.44 | |
| ≡ | Polen Capital Management | Buy | 35,649 | 0.00 | |
| Q1 2025 | |||||
| ≡ | Viking Global Investors | Reduce 12.20% | 3,065,616 | 0.34 | |
| Q3 2023 | |||||
| ≡ | Viking Global Investors | Reduce 5.63% | 1,500,000 | 0.16 | |
| Q2 2019 | |||||
| ≡ | Viking Global Investors | Buy | 26,620,991 | 3.23 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.